| Literature DB >> 35719807 |
Nurul Inaas Mahamad Apandi1,2, Anand Ramanathan1,3, Siti Mazlipah Ismail1,3, Kannan Ranganathan4.
Abstract
Histological variants of oral squamous cell carcinoma (OSCC) include verrucous, basaloid, spindle cell, adenosquamous, papillary, and acantholytic types. Clear-cell changes in OSCC are rare. We report a case of a 65-year-old male Chinese patient who presented with a swelling in the lower-left mandible for three weeks, causing ill-fitting of his lower denture and an ulcer on the floor of the mouth. Histologically, the lesion showed a dense proliferation of malignant tumor cells arranged in islands and sheets consisting of squamoid cells intermixed with signet ring-shaped clear cells. The clear cells were negative for mucicarmine, periodic acid Schiff (PAS), periodic acid Schiff-diastase (PAS-D), and alcian blue (AB). Immunohistochemistry showed the tumor cells were immuno-positive for cytokeratin (CK) and p63, but CK7, CK20, and S100 were immuno-negative. Therefore, a metastatic tumor in the oral cavity was suggested. However, the CT scan did not show any primary tumors in other sites. Histopathologically, the surgical specimen showed signet-ring-shaped clear cells in the stroma with squamoid cells invading the underlying connective tissue from the surface epithelium, suggesting a diagnosis of clear cell changes in OSCC. Follow-up showed recurrent OSCC at the base of the tongue with lymph node metastasis and distant metastasis in the lung. Only a few cases of clear-cell changes have been reported, with most having a poor prognosis. This case report adds one more case of clear cell changes in the OSCC with a poor prognosis. We reviewed the literature to understand their clinical behavior. Due to the rarity of its (clear cell changes) occurrence, further research is required in order to obtain a better understanding of the clinical behavior and prognosis of these clear cell changes seen in OSCC.Entities:
Keywords: clear cell changes; clinical behavior; diagnosis; oral cancer; oral squamous cell carcinoma; prognosis; variant
Year: 2022 PMID: 35719807 PMCID: PMC9200516 DOI: 10.7759/cureus.25057
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Intraoral photographs show (A) a swelling in the lower-left premolar-molar region (white arrows) and two white patches (black arrows) and (B) an irregular ulcer on the right side of the floor of the mouth (white arrows)
Figure 2Photomicrograph shows numerous neoplastic cells having signet ring-shaped with clear cytoplasm and eccentrically placed nucleus
Stain: H&E; Original magnification: 100X
Figure 3Photomicrographs show neoplastic cells that are immunopositivite for (A) p63 (Original magnification: 100x) and (B) CK (Original magnification: 200x)
Figure 4Photomicrographs show neoplastic tumor cells that are immunonegative for (A) CK7 (Original magnification: 100x) and (B) CK20 (Original magnification: 100x)
Figure 5(A) Intraoral photograph shows a large growth involving the left side floor of the mouth extending from the midline to the edentulous molar region. (B) Photograph shows PET-CT image (axial cut) of the primary tumor in the left side body of the mandible
PET-CT: positron emission tomography-computed tomography
Figure 6Photomicrograph shows (A) sheets of infiltrating squamoid tumor cells from the surface (Stain: H&E; Original magnification: 20X) and (B) numerous neoplastic cells showing clear cell changes (Stain: H&E; Original magnification: 200X)
Figure 7Photograph shows PET-CT image (A) of the recurrent tumor on the base of the tongue (blue circle) and (B) three metastatic nodules in the right lung (green arrows)
PET-CT: positron emission tomography-computed tomography
Reported cases of clear cell changes in oral squamous cell carcinoma
CCRT: concurrent chemoradiation therapy
| Author | Year | Age | Gender | Site | Treatment and outcome |
| Frazier et al [ | 2012 | 59 | Female | Mandibular gingiva | Referred for Oncology consultation, however, defaulted and was lost to follow-up. |
| Kumar et al [ | 2012 | 70 | Female | Anterior maxilla and right mandible (2 sites) | Surgical excision of the lesion and bilateral supra-omohyoid neck dissection. Unfortunately, the patient succumbed within 2 months of follow-up. |
| Romanach et al [ | 2014 | 60 | Female | Buccal mucosa extending to the soft palate | Surgical removal with adjuvant radiotherapy. 6 months local recurrence with no regional metastasis and no recurrence after 12 months post second surgery. |
| Nainani et al [ | 2014 | 52 | Male | Buccal mucosa | Complete excision of primary lesions with bilateral supraomohyoid neck dissection was done. Metastasis to Level Ia was observed. The patient was advised for radiotherapy but declined and succumbed to dissemination disease after 3 months. |
| Kaliamoorthy et al [ | 2015 | 35 | Female | Tongue and lingual vestibule | Referred to the cancer institute for comprehensive management. |
| Devi et al [ | 2016 | 55 | Male | Maxillary alveolar ridge | Hemimaxillectomy with left radical neck dissection. Reviewed 5 months post-operation and still undergoing radiotherapy. |
| Khoury et al [ | 2017 | 66 | Female | Tongue, the floor of the mouth, and the retromolar fossa | The patient underwent subtotal glossectomy, partial pharyngectomy, bilateral neck dissection, and simultaneous anterolateral thigh free flap reconstruction. 3 months after salvage surgery, a chest CT scan indicated metastasis to the left lung. The patient was scheduled for chemotherapy and a potential clinical trial. |
| Present case | 65 | Male | Floor of mouth | Wide excision of tumor at left mandible with segmental mandibulectomy along with bilateral extended supraomohyoid neck dissection. Reconstruction was done with a free fibula flap. Recurrence occurred at the base of the tongue 2 years and 2 months after initial treatment with 2 hypermetabolic lymph nodes on the left side of the neck in level II. The patient was given CCRT. Lung metastasis was noted. In the last review, the recurrent lesion on the base of the tongue, the level II lymph nodes, and the lung metastasis were resolved. The lung metastasis was reduced in size in December 2021. |